VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,130,092 | -1.9% | 42,011 | +9.8% | 0.20% | +1.5% |
| Q2 2023 | $1,152,031 | +8.8% | 38,261 | +16.8% | 0.20% | +4.2% |
| Q1 2023 | $1,059,131 | +29.0% | 32,750 | +14.3% | 0.19% | +24.2% |
| Q4 2022 | $820,819 | +23.1% | 28,650 | +3.5% | 0.15% | +15.9% |
| Q3 2022 | $667,000 | -9.4% | 27,685 | +3.0% | 0.13% | -5.0% |
| Q2 2022 | $736,000 | -28.4% | 26,885 | +0.2% | 0.14% | -16.8% |
| Q1 2022 | $1,028,000 | +2.3% | 26,825 | -8.2% | 0.17% | -0.6% |
| Q4 2021 | $1,005,000 | +21.7% | 29,225 | +4.3% | 0.17% | +19.1% |
| Q3 2021 | $826,000 | +3654.5% | 28,025 | +4278.9% | 0.14% | +3425.0% |
| Q2 2021 | $22,000 | +4.8% | 640 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $21,000 | +2000.0% | 640 | +4166.7% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |